Alternative VanHAX Promoters and Increased VanA-plasmid Copy Number Resurrect Silenced Glycopeptide Resistance in Enterococcus Faecium
Overview
Authors
Affiliations
Background: Vancomycin variable enterococci (VVE) are van-positive isolates with a susceptible phenotype that can convert to a resistant phenotype during vancomycin selection.
Objectives: To describe a vancomycin-susceptible vanA-PCR positive ST203 VVE Enterococcus faecium isolate (VVESwe-S) from a liver transplantation patient in Sweden which reverted to resistant (VVESwe-R) during in vitro vancomycin exposure.
Methods: WGS analysis revealed the genetic differences between the isolates. Expression of the van-operon was investigated by qPCR. Fitness and stability of the revertant were investigated by growth measurements, competition and serial transfer.
Results: The VVESwe-R isolate gained high-level vancomycin (MIC >256 mg/L) and teicoplanin resistance (MIC = 8 mg/L). VVESwe-S has a 5'-truncated vanR activator sequence and the VVESwe-R has in addition acquired a 44 bp deletion upstream of vanHAX in a region containing alternative putative constitutive promoters. In VVESwe-R the vanHAX-operon is constitutively expressed at a level comparable to the non-induced prototype E. faecium BM4147 strain. The vanHAX operon of VVESwe is located on an Inc18-like plasmid, which has a 3-4-fold higher copy number in VVESwe-R compared with VVESwe-S. Resistance has a low fitness cost and the vancomycin MIC of VVESwe-R decreased during in vitro serial culture without selection. The reduction in MIC was associated with a decreased vanA-plasmid copy number.
Conclusions: Our data support a mechanism by which vancomycin-susceptible VVE strains may revert to a resistant phenotype through the use of an alternative, constitutive, vanR-activator-independent promoter and a vanA-plasmid copy number increase.
McInnes R, Snaith A, Dunn S, Papangeli M, Hardy K, Hussain A NPJ Antimicrob Resist. 2025; 2(1):2.
PMID: 39843953 PMC: 11702846. DOI: 10.1038/s44259-023-00017-0.
"Keeping us on our toes": a review of what clinicians need to know about vancomycin-variable .
Hawkins M, Medvedeva N, Wang H, Banaei N, Holubar M Antimicrob Steward Healthc Epidemiol. 2024; 4(1):e200.
PMID: 39563924 PMC: 11574585. DOI: 10.1017/ash.2024.449.
Prevalence and Molecular Characterization of Vancomycin Variable Isolated From Clinical Specimens.
Yoo I, Kwon J, Lee M, Jung S, Kim J, Ha S Ann Lab Med. 2024; 44(5):450-454.
PMID: 38475872 PMC: 11169778. DOI: 10.3343/alm.2023.0430.
Genetic analysis of vancomycin-variable Enterococcus faecium clinical isolates in Italy.
Coccitto S, Cinthi M, Simoni S, Pocognoli A, Zeni G, Mazzariol A Eur J Clin Microbiol Infect Dis. 2024; 43(4):673-682.
PMID: 38296911 PMC: 10965585. DOI: 10.1007/s10096-024-04768-0.
Onaran Acar B, Cengiz G, Goncuoglu M Iran J Vet Res. 2024; 24(3):182-192.
PMID: 38269016 PMC: 10804430. DOI: 10.22099/IJVR.2023.47465.6855.